Term
Role of Opioid Analgesics |
|
Definition
Agent of choice for moderate to severe pain (especially visceral)
Used for limited perioid of time in most patients |
|
|
Term
Patient Controlled Analgesics |
|
Definition
Keeps pain under control
Gets the patient involved
Proper patient selection is critical
Ideal for acute, sharp, post-op pain
Patients activate pump when they feel a little pain
Y-tubing site close to injection site |
|
|
Term
|
Definition
Programming Errors
Pump Failure
PCA by proxy => family member thinking pt is in pain |
|
|
Term
Patient Controlled Analgesia
Adult Dosing
Intermittent Dose, Lockout Interval, Hour Limit, 4 Hour Limit, Basal Rate |
|
Definition
Adult: 25-50 mcg/kg or 2-4 mg morphine
Intermittent Dose: 1 mg
Lockout Interval: 5-10 minutes
Hour Limit: 5 mg
4 Hour Limit: 15-20 mg
Basal Rate: 2 mg/hr |
|
|
Term
Patient Controlled Analgesia
Potential Benefits of Fentanyl
(2) |
|
Definition
Short duration may aid tiration
Less NV, urinary retention, and sedation |
|
|
Term
Patients who will benefit from basal rate
(4) |
|
Definition
Patient who undergo major surgery
Patient who hits limit every hour
Patient with high dosing requirement during first 24-48 hours
Patient who wake up frequently at night with pain
|
|
|
Term
Monitoring Patients PCA
(5) |
|
Definition
Every 4 hours until stable
Basal Rate
Number of Attempts
Number of Injections
Ask patient how they feel: HR, BP, Pain Scale |
|
|
Term
|
Definition
Cut or stop basal rate when patient stops attempts
If patient waits too long between injections, re-bolus
If patient needs more drug: increase intermittent dose by 50% increasing 1 and 4 hr limit
If this increase dose not work ,increase dose by 50% of the first increase
Always reassess if patient needs to be re-bolused!!! |
|
|
Term
Epidural/Inthrathecal Analgesia |
|
Definition
Usually intentded for short-term use
Useful post-op and some OB patients when epidural catheter is already in place
Useful when pts can NO longer tolerate SE associated with Oral or IV
Useful in terminal patients Not achieving pain relief by conventional means
Used in some pain patients when other treatment proves unsuccessful |
|
|
Term
Epidural/Intrathecal Analgesia
Monitoring
SEs (2) |
|
Definition
Patients must be monitored and stabalized over 48 hour period
Any respiratory depression may be delayed
Itching and Urinary Retention more Common
Risk of infection |
|
|
Term
Epidural/Intrathecal Analgesia
Dosing is Emperic for (3) |
|
Definition
Morphine
Hydromorphone
Fentanyl
USE ONLY PRESERVATIVE FREE PRODUCTS AND DILUENTS |
|
|
Term
DepoDur
Morphine Extended-Release Liposome Injection |
|
Definition
Provides analgesia up to 48 hours
Administered into lumbar spaces prior to surgery
Eliminates need for catheter and pumo
Stored in refrigerator must be used with 4 hours after withdrawing from vial
|
|
|
Term
Clonidine-Duraclon
Ziconotide-Prialt
MOAs |
|
Definition
Blocks Alpha-2 Receptor (Best for Neuropathic Pain)
Synthetic peptide from sea snail venom indicated for IT injection to manage severe chronic pain in patients who do NOT respond to other therapies
|
|
|
Term
Managemtn of Chronic Pain
Non-visceral/Non-somatic
Mild to Moderate Pain (4)
Step 1 Options (3) |
|
Definition
Arthritis
Neuropathies
Fibromyalgia
Low back pain
APAP
NSAIDs
Tramadol
with Routine Dosing
|
|
|
Term
Management of Chronic Pain
Non-Visceral/Non-Somatic
Step 2 Options (2) |
|
Definition
Use SR forms of Step 1 drugs
Long Acting NSAIDs
ER forms of Tramadol
Ultram ER titrate over 5 days
Ryzolt tirate over 5 days |
|
|
Term
Management of Chronic Pain
Non-Visceral/Non-Somatic
Step 3 Options (3) |
|
Definition
Continue Step 1 and 2 drugs
Avoid chronic use of opioids if possible
Conside use of buprenorphine patch |
|
|
Term
Management of Chronic Pain
Non-Visceral/Non-Somatic
Lower Back Pain
Treatment Guidelines (5) |
|
Definition
NSAIDs or APAP
Heat massage, activity, rehabilitation, acupuncture, spinal manipulation
Injectable corticosteroids if there is evidence of inflammation
Muscle Relaxants for acute use only
TCS, gabapentin, topirimate (mixed results)
Opioids should be reserved for pts with severe pain NOT relieved by other agents (less effect with chronic use) |
|
|
Term
|
Definition
Often the result of loss of inhibitory activities of the descending pathway on pain transmission |
|
|
Term
Conditions associated with Neuropathic Pain
(10) |
|
Definition
Diabetic Neuropathies
Lower Back Pain
Trigeminal Neuralgia
HIV Sensory Neuropathy
Tumor Infiltration
Post-Herpetic Neuralgia
Cancer Pain
Some Headaches
Spinal Cord Injury
Phantom Limb Pain |
|
|
Term
|
Definition
Severe Pain
Extremely sensitive to tough or temperature
Feeling of clothing against skin is painful
Condition can last for months
|
|
|
Term
Treatment of Neuropathic Pain
General Principles
(5) |
|
Definition
Initiate one drug at a time
Use drugs with the lowest SE profile
Start at low dose, slowly increase dose evaluating benefit vs. SE
for tx failure, try alternative agents within same class
Education: full benefit may take days to weeks with full pain relief NOT expected |
|
|
Term
Treatment of Neuropathic Pain
Antidepressants
MOA
Effect
Medications
(4) |
|
Definition
Agents with activity against NE and serotonin most effective
Analgesic effect takes at least 1 week
Amitriptyline (Elavil)
Nortriptyline (Pamelor)
Desipramine (Norpramin)
start at 10-25 mg po hs (max 100-150 mg)
Venlafaxine (Effexor XR) 150-225 mg/day |
|
|
Term
Treatment of Neuropathic Pain
Duloxentine (Cymbalta) |
|
Definition
30-60mg/day
Not superior to other antidepressants
Avoid in pts with liver disease
Urinary hesitancy reported |
|
|
Term
Treatment of Neuropathic Pain
MOA
Medications
(6) |
|
Definition
Inhibit glutamate activity
Enhance GABA activity
Carbamazepine
Phenytoin
Gabapentin
Pregabalin
Lamotrigine
Topiramate |
|
|
Term
Gabapentin
Dosing
Gabapentin Extend-Release (Gralise) |
|
Definition
900-1800 mg/day
max: 3600 mg/day
Start at 100 mg TID
Taper when d/c
Marketed for post-herpetic neuralgia
Taken once daily with evening meal
Dose is titrated over 2 weeks to max of 1800 mg |
|
|
Term
|
Definition
Start at 75 mg BID
Titrate to 150 mg BID
No benefit at doses > 300 mg/day
SE dose related
d/c gradually to avoid withdrawl symptoms |
|
|
Term
|
Definition
Depletes stores of Substance P which inhibits pain transmission and inflammation
For pain from arthritis and neuropathies
Apply 3-4 times daily
A burning sensation may occur
Wash hands thoroughly with soap and water
Inital relief is usually noted within 1-2 weeks
Daily application is necessary to sustain pain relief |
|
|
Term
Capasaicin 8% Patch (Qutenza) |
|
Definition
Only indicated for PHN
Apply for 1 hours q 3 months
Design for application by HCP
Use only NITRILE GLOVES
Causes slight elevation in BP |
|
|
Term
Lidocaine Patches 5% (Lidoderm) |
|
Definition
Local Anesthetic
No more than 3 (4) patches at a time
Patches can be cut to fit affected area
on for 12 hours, then off for 12 hours
Apply on intact skin
|
|
|
Term
Treatment of Neuropathic Pain
Other Therapies
(6) |
|
Definition
Muscle relaxants/Antispasmotic => Tizandiine, Baclofen
Lidocaine injections/Alcohol injections
Clonidine (topical patches)
Ketamine Injection or 5% gel (NMDA receptor antagonist)
Botox injections (paralyzes nerves and muscles) |
|
|
Term
Fibromyalgia
Characterized by (2)
Statistics
Causes
Sx (4) |
|
Definition
Generalized muscle pain, fatigue
Imbalance of serotonin and NE are thought to be involved
Achiness ALL over
Inability to sleep
Stiffiness on wakening
Tiredness during the day |
|
|
Term
Fibromyalgia
Criteria Classification
(4) |
|
Definition
Pain left/right sdie
Pain above/below waist
Pain for > 3 months
Palpable pain at 11 of 18 indentified tender point sites |
|
|
Term
Fibromyalgia
Therapies with supporting evidence for use
(6) |
|
Definition
Amitriptyline
Cyclobenzaprine
Duloxetine
Venlafaxine
Tramadol
Pregabalin |
|
|
Term
Treatment of Fibromyalgia
Milnacipran (Savella) |
|
Definition
SNRI
Only indicated for fibromyalgia
50-100 mg BID
Nausea is common
Monitor BP and HR
|
|
|
Term
Fibromyalgia
Non-pharmacological Treatment Options
(3) |
|
Definition
Exercise and muscle strengthening
Cognitive behavioral therapy
Patient education |
|
|